NetworkNewsBreaks – Canopy Rivers Inc.’s (TSX.
Post# of 87
Dynamic plant-based food and beverage company Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) today announced receipt of a Health Canada cultivation license for Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and its portfolio company, Spot Therapeutics Inc., for its Fredericton-based production and distribution facility. Per the update, the newly licensed facility will operate under the flagship Tweed banner, and the cultivation license initiates a long-term (25-year) cash flow stream anticipated to be approximately $2.85 million per year with commencement expected to begin in September 2019. “The long-term income stream from Spot, combined with our existing royalty portfolio, will further stabilize Canopy Rivers’ operating cash flow profile and provide us with additional financial resources to deploy as we continue to make investments in industry verticals we believe offer long-term strategic value for our portfolio partners and shareholders,” Canopy Rivers CFO Eddie Lucarelli said in the news release.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer